Northern Trust
ABOS icon

Northern Trust’s Acumen Pharmaceuticals ABOS Stock Holding History

Northern Trust’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$963K Buy
360,744
+285,532
+380% +$705K ﹤0.01% 3479
2026
Q1 		$178K Hold
75,212
– – ﹤0.01% 3978
2025
Q4 		$159K Buy
75,212
+10,258
+16% +$20.4K ﹤0.01% 4047
2025
Q3 		$111K Sell
64,954
-208
-0.3% -$288 ﹤0.01% 4112
2025
Q2 		$75.6K Sell
65,162
-224,674
-78% -$242K ﹤0.01% 4168
2025
Q1 		$319K Sell
289,836
-17,779
-6% -$25.4K ﹤0.01% 3770
2024
Q4 		$529K Sell
307,615
-1,235
-0.4% -$2.97K ﹤0.01% 3634
2024
Q3 		$766K Buy
308,850
+238,762
+341% +$648K ﹤0.01% 3442
2024
Q2 		$170K Buy
70,088
+13,315
+23% +$42.4K ﹤0.01% 3913
2024
Q1 		$230K Buy
56,773
+95
+0.2% +$358 ﹤0.01% 3846
2023
Q4 		$218K Buy
56,678
+488
+0.9% +$1.45K ﹤0.01% 3874
2023
Q3 		$233K Buy
56,190
+24,096
+75% +$149K ﹤0.01% 3746
2023
Q2 		$154K Sell
32,094
-64
-0.2% -$306 ﹤0.01% 3914
2023
Q1 		$131K Sell
32,158
-2,226
-6% -$11.6K ﹤0.01% 4009
2022
Q4 		$186K Buy
34,384
+8,642
+34% +$58.1K ﹤0.01% 3900
2022
Q3 		$259K Buy
25,742
+4,196
+19% +$24.1K ﹤0.01% 3748
2022
Q2 		$101K Sell
21,546
-194,622
-90% -$731K ﹤0.01% 4162
2022
Q1 		$845K Buy
216,168
+121,184
+128% +$659K ﹤0.01% 3506
2021
Q4 		$642K Buy
94,984
+7,583
+9% +$83.4K ﹤0.01% 3720
2021
Q3 		$1.3M Buy
+87,401
New +$1.45M ﹤0.01% 3461

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Northern Trust's ABOS Position: Q2 2026 in Review

Northern Trust increased its Acumen Pharmaceuticals (ABOS) stake by 380% in Q2 2026, buying an estimated $705K and bringing the position to 360,744 shares worth $963K. The position accounts for ﹤0.01% of the portfolio, ranked #3479.

Northern Trust first reported a position in ABOS in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.3M in Q3 2021. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Northern Trust held 360,744 shares of Acumen Pharmaceuticals worth $963K as of Q2 2026.
  • Northern Trust bought 285,532 Acumen Pharmaceuticals shares in Q2 2026, an estimated $705K.
  • Acumen Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3479 holding.
  • Northern Trust first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's Acumen Pharmaceuticals position peaked at $1.3M in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.